Holen Sie sich die Stockscreener-App
19.78
0.68%
0.14
Schlusskurs vom Vortag:
$19.64
Offen:
$19.75
24-Stunden-Volumen:
2.15M
Relative Volume:
0.26
Marktkapitalisierung:
$13.64B
Einnahmen:
$2.87B
Nettoeinkommen (Verlust:
$250.10M
KGV:
62.05
EPS:
0.3188
Netto-Cashflow:
$1.13B
1W Leistung:
+2.14%
1M Leistung:
+21.09%
6M Leistung:
+10.84%
1J Leistung:
+17.56%
1-Tages-Spanne:
$19.61
$19.89
1-Wochen-Bereich:
$19.20
$19.89
52-Wochen-Spanne:
$15.70
$19.91
Healthpeak Properties Inc Stock (DOC) Company Profile
Firmenname
Healthpeak Properties Inc
Sektor
Telefon
949-407-0700
Adresse
4600 SOUTH SYRACUSE STREET, DENVER, WI
Compare DOC vs WELL, VTR, OHI, CTRE
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
DOC
Healthpeak Properties Inc
|
19.78 | 13.54B | 2.87B | 250.10M | 1.13B | 0.3188 |
WELL
Welltower Inc
|
215.91 | 152.48B | 11.75B | 1.46B | 2.19B | -0.6014 |
VTR
Ventas Inc
|
88.26 | 42.78B | 6.13B | 272.21M | 1.38B | 0.5521 |
OHI
Omega Healthcare Investors Inc
|
47.91 | 14.37B | 1.24B | 655.98M | 857.80M | 2.063 |
CTRE
Caretrust Reit Inc
|
41.08 | 9.69B | 522.75M | 333.94M | 397.14M | 1.5617 |
Healthpeak Properties Inc Stock (DOC) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-04-20 | Eingeleitet | UBS | Neutral |
| 2026-02-05 | Herabstufung | Argus | Buy → Hold |
| 2026-01-09 | Eingeleitet | Goldman | Neutral |
| 2025-12-16 | Herabstufung | Jefferies | Buy → Hold |
| 2025-10-01 | Eingeleitet | Cantor Fitzgerald | Neutral |
| 2025-09-15 | Hochstufung | Raymond James | Mkt Perform → Outperform |
| 2025-08-20 | Herabstufung | Deutsche Bank | Buy → Hold |
| 2025-07-29 | Herabstufung | Scotiabank | Sector Outperform → Sector Perform |
| 2025-01-15 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2024-10-21 | Hochstufung | Deutsche Bank | Hold → Buy |
| 2024-05-03 | Hochstufung | Wedbush | Neutral → Outperform |
| 2024-04-26 | Hochstufung | Exane BNP Paribas | Neutral → Outperform |
| 2024-04-22 | Fortgesetzt | Mizuho | Buy |
| 2024-04-01 | Hochstufung | BofA Securities | Underperform → Buy |
| 2024-03-25 | Fortgesetzt | Wells Fargo | Equal Weight |
| 2024-03-08 | Fortgesetzt | RBC Capital Mkts | Outperform |
| 2024-01-05 | Herabstufung | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2023-05-26 | Eingeleitet | JMP Securities | Mkt Outperform |
| 2023-04-20 | Eingeleitet | Wells Fargo | Underweight |
| 2022-12-14 | Hochstufung | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2022-10-28 | Eingeleitet | JP Morgan | Neutral |
| 2022-08-05 | Herabstufung | Colliers Securities | Buy → Neutral |
| 2022-06-03 | Eingeleitet | CapitalOne | Equal Weight |
| 2022-05-19 | Herabstufung | BofA Securities | Neutral → Underperform |
| 2022-04-26 | Eingeleitet | Barclays | Overweight |
| 2022-02-01 | Eingeleitet | Credit Suisse | Neutral |
| 2022-01-07 | Herabstufung | BMO Capital Markets | Outperform → Market Perform |
| 2021-09-13 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2021-08-20 | Herabstufung | Raymond James | Outperform → Mkt Perform |
| 2021-06-14 | Herabstufung | Robert W. Baird | Outperform → Neutral |
| 2021-03-15 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2021-01-13 | Hochstufung | Jefferies | Hold → Buy |
| 2020-12-14 | Herabstufung | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2020-11-11 | Herabstufung | RBC Capital Mkts | Outperform → Sector Perform |
| 2020-09-30 | Fortgesetzt | Robert W. Baird | Outperform |
| 2020-09-02 | Fortgesetzt | Stifel | Buy |
| 2020-04-07 | Herabstufung | Citigroup | Buy → Neutral |
| 2020-04-01 | Hochstufung | Berenberg | Hold → Buy |
| 2020-03-16 | Herabstufung | BTIG Research | Buy → Neutral |
| 2020-03-09 | Hochstufung | BMO Capital Markets | Market Perform → Outperform |
| 2020-02-27 | Hochstufung | CapitalOne | Equal Weight → Overweight |
| 2019-12-20 | Eingeleitet | Mizuho | Buy |
| 2019-12-12 | Hochstufung | Citigroup | Neutral → Buy |
| 2019-11-26 | Hochstufung | Stifel | Hold → Buy |
| 2019-10-14 | Eingeleitet | BofA/Merrill | Neutral |
| 2019-06-20 | Eingeleitet | Citigroup | Neutral |
| 2019-05-02 | Herabstufung | CapitalOne | Overweight → Equal Weight |
| 2018-08-03 | Hochstufung | CapitalOne | Equal Weight → Overweight |
| 2018-04-25 | Herabstufung | Stifel | Buy → Hold |
| 2018-03-01 | Bestätigt | B. Riley FBR, Inc. | Buy |
| 2018-01-05 | Bestätigt | Robert W. Baird | Outperform |
| 2017-11-06 | Hochstufung | Hilliard Lyons | Long-term Buy → Buy |
Alle ansehen
Healthpeak Properties Inc Aktie (DOC) Neueste Nachrichten
What is Janus Living and Why is Healthpeak Spinning it Off - Kavout
A Look At Healthpeak Properties (DOC) Valuation After Strong Recent Share Price Momentum - Yahoo Finance
Healthpeak Properties Inc. stock underperforms Wednesday when compared to competitors despite daily gains - MarketWatch
Healthpeak Properties stock: Is DOC underperforming the real estate sector? - MSN
Healthpeak’s S&P 500 Rally Raises A Big Valuation Question - Kalkine Media
Analysts Offer Insights on Real Estate Companies: Rayonier (RYN), Weyerhaeuser (WY) and Healthpeak Properties (DOC) - The Globe and Mail
Assessing Healthpeak Properties (DOC) Valuation After Recent Share Price Momentum - simplywall.st
Verizon and 4 More Stocks With 5% Dividend Yields—and Market-Beating Returns - Barron's
Mizuho Securities Maintains Healthpeak Properties(DOC.US) With Buy Rating, Raises Target Price to $21 - Moomoo
New York Life Investment Management LLC Boosts Holdings in Healthpeak Properties, Inc. $DOC - MarketBeat
Healthpeak (DOC) CEO makes 120,372-unit OP equity gifts, retains stake - Stock Titan
How Investors Are Reacting To Healthpeak Properties (DOC) Earnings Upgrade And Completed Share Buyback - simplywall.st
Are Wall Street analysts bullish on Healthpeak Properties stock? - MSN
Verizon and 4 Other Stocks With 5% Yields—and Market-Beating Returns - Barron's
Baird Raises its Price Target on Healthpeak Properties (DOC) - Insider Monkey
Mizuho Adjusts Price Target on Healthpeak Properties to $21 From $18, Maintains Outperform Rating - Moomoo
JAN Stock Price, Quote & Chart | JANUS LIVING INC CL-A-1 (NYSE:JAN) - ChartMill
Healthpeak Properties stock (US42226K1051): analyst moves and solid earnings support 2026 rally - AD HOC NEWS
10 Fastest Growing S&P 500 Stocks to Buy Now - Insider Monkey
Healthpeak Properties, Inc.: - marketscreener.com
Healthpeak Properties Q1 earnings call highlights - MSN
Healthpeak Properties Inc. stock outperforms competitors despite losses on the day - MarketWatch
BNP Paribas Adjusts PT on Healthpeak Properties to $22 From $21, Maintains Outperform Rating - Moomoo
[SCHEDULE 13G] Janus Living, Inc. Passive Investment Disclosure (>5%) - Stock Titan
DOC Maintained by RBC Capital -- Price Target Raised to $21.00 - GuruFocus
Healthpeak Properties Is Maintained at Outperform by RBC Capital - Moomoo
Healthpeak Properties (NYSE:DOC) Hits New 1-Year High After Analyst Upgrade - MarketBeat
RBC Raises Price Target on Healthpeak Properties to $21 From $20, Keeps Outperform Rating - marketscreener.com
VIRGINIA RETIREMENT SYSTEMS ET Al Has $5.15 Million Position in Healthpeak Properties, Inc. $DOC - MarketBeat
Healthpeak Properties: A Healthy Balance Sheet And Growth Opportunities Outweigh Risk Concerns - Seeking Alpha
Insider Sell: Scott Bohn Sells Shares of Healthpeak Properties I - GuruFocus
Scott Bohn Sells 10,989 Shares of Healthpeak Properties (NYSE:DOC) Stock - MarketBeat
Healthpeak Properties Inc. stock underperforms Wednesday when compared to competitors - MarketWatch
Healthpeak (NYSE: DOC) CDO Scott Bohn sells 10,989 shares - Stock Titan
DOC Maintained by UBS -- Price Target Raised to $19.00 - GuruFocus
JPMorgan Chase (DOC) holds 43.09M shares, 6.1% stake in Healthpeak (05/13/2026) - Stock Titan
UBS Raises Healthpeak Properties Price Target to $19 From $17, Neutral Rating Kept - marketscreener.com
DOC Maintained by Baird -- Price Target Raised to $21.00 - GuruFocus
Healthpeak Properties stock (US42226K1051): Baird, Citi and Jefferies raise price targets - AD HOC NEWS
Jefferies Adjusts Price Target on Healthpeak Properties to $19 From $16, Maintains Hold Rating - marketscreener.com
Baird Adjusts Price Target on Healthpeak Properties to $21 From $19, Maintains Outperform Rating - marketscreener.com
Healthpeak Properties: Lab Weakness Creates A Major Re-Rating Opportunity (NYSE:DOC) - Seeking Alpha
DOC Maintained by Citigroup -- Price Target Raised to $20.00 - GuruFocus
[144] HEALTHPEAK PROPERTIES, INC. SEC Filing - Stock Titan
Evercore ISI Downgrades Healthpeak Properties to In Line From Outperform, Adjusts Price Target to $21 From $20 - Moomoo
Citigroup Adjusts PT on Healthpeak Properties to $20 From $17.50, Maintains Neutral Rating - marketscreener.com
Healthpeak Properties stock (US42226K1051): Evercore cuts to In-Line after Q1 beat and 18% rally - AD HOC NEWS
Evercore Downgrades Healthpeak Properties(DOC.US) to Hold Rating, Raises Target Price to $21 - Moomoo
Healthpeak Properties declares $0.1017 dividend - MSN
Healthpeak Properties stock (US42226K1051): Q1 beat sparks 18% rally - AD HOC NEWS
Healthpeak Properties Q1 FFOA tops estimates on steady leasing momentum - MSN
Finanzdaten der Healthpeak Properties Inc-Aktie (DOC)
Umsatz
Nettogewinn
Free Cashflow
ENV
2.47%
0.48%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):